Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease.

Libé R, Jazeron JF, Louiset E, Groussin L.

Endocrine. 2018 Sep 24. doi: 10.1007/s12020-018-1757-3. [Epub ahead of print] No abstract available.

PMID:
30251165
2.

Clinical and molecular prognostic factors in adrenocortical carcinomas.

Libé R.

Minerva Endocrinol. 2018 Sep 12. doi: 10.23736/S0391-1977.18.02900-0. [Epub ahead of print]

PMID:
30221891
3.

Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.

Renaudin K, Smati S, Wargny M, Al Ghuzlan A, Aubert S, Leteurtre E, Patey M, Sibony M, Sturm N, Tissier F, Amar L, Bertherat J, Berthozat C, Chabre O, Do Cao C, Haissaguerre M, Pierre P, Briet C, Vezzosi D, Lifante JC, Pattou F, Mirallie E, Baudin E, Cariou B, Libe R, Drui D; for Comete-Cancer Network.

Mod Pathol. 2018 Nov;31(11):1708-1716. doi: 10.1038/s41379-018-0077-8. Epub 2018 Jun 19.

PMID:
29921900
4.

MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.

Agosta C, Laugier J, Guyon L, Denis J, Bertherat J, Libé R, Boisson B, Sturm N, Feige JJ, Chabre O, Cherradi N.

Int J Cancer. 2018 Aug 15;143(4):944-957. doi: 10.1002/ijc.31363. Epub 2018 Mar 30.

PMID:
29516499
5.

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B-Secreting Adrenocortical Carcinoma.

Espiard S, Lahlou N, Sibony M, Louiset E, Bienvenu M, Bertherat J, Dousset B, Groussin L, Libé R.

J Endocr Soc. 2017 Jan 12;1(1):46-50. doi: 10.1210/js.2016-1009. eCollection 2017 Jan 1.

6.

Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma.

Garinet S, Nectoux J, Neou M, Pasmant E, Jouinot A, Sibony M, Orhant L, Pipoli da Fonseca J, Perlemoine K, Bricaire L, Groussin L, Soubrane O, Dousset B, Libe R, Letourneur F, Bertherat J, Assié G.

Endocr Relat Cancer. 2018 Mar;25(3):L13-L17. doi: 10.1530/ERC-17-0467. Epub 2017 Dec 6. No abstract available.

PMID:
29212777
7.

Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.

Vezzosi D, Do Cao C, Hescot S, Bertherat J, Haissaguerre M, Bongard V, Drui D, De La Fouchardière C, Illouz F, Borson-Chazot F, Djobo B, Berdelou A, Tabarin A, Schlumberger M, Briet C, Caron P, Leboulleux S, Libe R, Baudin E; For Comete-Cancer Network.

Horm Cancer. 2018 Feb;9(1):62-69. doi: 10.1007/s12672-017-0313-6. Epub 2017 Oct 25.

PMID:
29071575
8.

Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.

Sbiera S, Sbiera I, Ruggiero C, Doghman-Bouguerra M, Korpershoek E, de Krijger RR, Ettaieb H, Haak H, Volante M, Papotti M, Reimondo G, Terzolo M, Luconi M, Nesi G, Mannelli M, Libé R, Ragazzon B, Assié G, Bertherat J, Altieri B, Fadda G, Rogowski-Lehmann N, Reincke M, Beuschlein F, Fassnacht M, Lalli E.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3491-3498. doi: 10.1210/jc.2017-00984.

PMID:
28911143
9.

DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.

Jouinot A, Assie G, Libe R, Fassnacht M, Papathomas T, Barreau O, de la Villeon B, Faillot S, Hamzaoui N, Neou M, Perlemoine K, Rene-Corail F, Rodriguez S, Sibony M, Tissier F, Dousset B, Sbiera S, Ronchi C, Kroiss M, Korpershoek E, de Krijger R, Waldmann J, K D, Bartsch, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Sturm N, Luconi M, Mantero F, Mannelli M, Cohen R, Kerlan V, Touraine P, Barrande G, Groussin L, Bertagna X, Baudin E, Amar L, Beuschlein F, Clauser E, Coste J, Bertherat J.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):923-932. doi: 10.1210/jc.2016-3205.

PMID:
27967600
10.

Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma.

Bahougne T, Imperiale A, Averous G, Chabrier G, Burnichon N, Gimenez-Roqueplo AP, Dali-Youcef N, Libe R, Baudin E, Roy C, Lang H, Kessler L.

Endocr Relat Cancer. 2017 Feb;24(2):L7-L11. doi: 10.1530/ERC-16-0431. Epub 2016 Nov 28. No abstract available.

PMID:
27895137
11.

PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.

Bram Z, Louiset E, Ragazzon B, Renouf S, Wils J, Duparc C, Boutelet I, Rizk-Rabin M, Libé R, Young J, Carson D, Vantyghem MC, Szarek E, Martinez A, Stratakis CA, Bertherat J, Lefebvre H.

JCI Insight. 2016 Sep 22;1(15):e87958.

12.

[Adrenocortical carcinoma and pregnancy].

Raffin-Sanson ML, Abiven G, Ritzel K, de Corbière P, Cazabat L, Zaharia R, Groussin L, Libe R, Bertherat J, Fassnacht M, Bertagna X.

Ann Endocrinol (Paris). 2016 Jun;77(2):139-47. doi: 10.1016/j.ando.2016.04.024. Epub 2016 May 9. Review. French.

PMID:
27172868
13.

Pregnancy in Women Previously Treated for an Adrenocortical Carcinoma.

de Corbière P, Ritzel K, Cazabat L, Ropers J, Schott M, Libé R, Koschker AC, Leboulleux S, Deutschbein T, Do Cao C, Hahner S, Drui D, Miehle K, Caron P, Waldmann J, Chabre O, Quinkler M, Touraine P, Villares Fragoso MC, Bertherat J, Bertagna X, Fassnacht M, Raffin-Sanson ML.

J Clin Endocrinol Metab. 2015 Dec;100(12):4604-11. doi: 10.1210/jc.2015-2341. Epub 2015 Oct 13.

PMID:
26461265
14.

Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.

Libé R, Borget I, Ronchi CL, Zaggia B, Kroiss M, Kerkhofs T, Bertherat J, Volante M, Quinkler M, Chabre O, Bala M, Tabarin A, Beuschlein F, Vezzosi D, Deutschbein T, Borson-Chazot F, Hermsen I, Stell A, Fottner C, Leboulleux S, Hahner S, Mannelli M, Berruti A, Haak H, Terzolo M, Fassnacht M, Baudin E; ENSAT network.

Ann Oncol. 2015 Oct;26(10):2119-25. doi: 10.1093/annonc/mdv329.

15.

Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment.

Libé R.

Front Cell Dev Biol. 2015 Jul 3;3:45. doi: 10.3389/fcell.2015.00045. eCollection 2015. Review.

16.

ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences.

Espiard S, Drougat L, Libé R, Assié G, Perlemoine K, Guignat L, Barrande G, Brucker-Davis F, Doullay F, Lopez S, Sonnet E, Torremocha F, Pinsard D, Chabbert-Buffet N, Raffin-Sanson ML, Groussin L, Borson-Chazot F, Coste J, Bertagna X, Stratakis CA, Beuschlein F, Ragazzon B, Bertherat J.

J Clin Endocrinol Metab. 2015 Jun;100(6):E926-35. doi: 10.1210/jc.2014-4204. Epub 2015 Apr 8.

17.

Primary Aldosteronism and ARMC5 Variants.

Zilbermint M, Xekouki P, Faucz FR, Berthon A, Gkourogianni A, Schernthaner-Reiter MH, Batsis M, Sinaii N, Quezado MM, Merino M, Hodes A, Abraham SB, Libé R, Assié G, Espiard S, Drougat L, Ragazzon B, Davis A, Gebreab SY, Neff R, Kebebew E, Bertherat J, Lodish MB, Stratakis CA.

J Clin Endocrinol Metab. 2015 Jun;100(6):E900-9. doi: 10.1210/jc.2014-4167. Epub 2015 Mar 30.

18.

SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

Papathomas TG, Oudijk L, Persu A, Gill AJ, van Nederveen F, Tischler AS, Tissier F, Volante M, Matias-Guiu X, Smid M, Favier J, Rapizzi E, Libe R, Currás-Freixes M, Aydin S, Huynh T, Lichtenauer U, van Berkel A, Canu L, Domingues R, Clifton-Bligh RJ, Bialas M, Vikkula M, Baretton G, Papotti M, Nesi G, Badoual C, Pacak K, Eisenhofer G, Timmers HJ, Beuschlein F, Bertherat J, Mannelli M, Robledo M, Gimenez-Roqueplo AP, Dinjens WN, Korpershoek E, de Krijger RR.

Mod Pathol. 2015 Jun;28(6):807-21. doi: 10.1038/modpathol.2015.41. Epub 2015 Feb 27.

19.

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.

Castro-Vega LJ, Letouzé E, Burnichon N, Buffet A, Disderot PH, Khalifa E, Loriot C, Elarouci N, Morin A, Menara M, Lepoutre-Lussey C, Badoual C, Sibony M, Dousset B, Libé R, Zinzindohoue F, Plouin PF, Bertherat J, Amar L, de Reyniès A, Favier J, Gimenez-Roqueplo AP.

Nat Commun. 2015 Jan 27;6:6044. doi: 10.1038/ncomms7044.

20.

Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.

Beuschlein F, Weigel J, Saeger W, Kroiss M, Wild V, Daffara F, Libé R, Ardito A, Al Ghuzlan A, Quinkler M, Oßwald A, Ronchi CL, de Krijger R, Feelders RA, Waldmann J, Willenberg HS, Deutschbein T, Stell A, Reincke M, Papotti M, Baudin E, Tissier F, Haak HR, Loli P, Terzolo M, Allolio B, Müller HH, Fassnacht M.

J Clin Endocrinol Metab. 2015 Mar;100(3):841-9. doi: 10.1210/jc.2014-3182. Epub 2015 Jan 5.

Supplemental Content

Loading ...
Support Center